<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01373255</url>
  </required_header>
  <id_info>
    <org_study_id>0043-08-EMC</org_study_id>
    <secondary_id>Acreta02</secondary_id>
    <nct_id>NCT01373255</nct_id>
  </id_info>
  <brief_title>Balloon Catheters in Cases of Abnormal Placentation</brief_title>
  <acronym>Accreta</acronym>
  <official_title>Balloon Catheter for Occlusion of the Pelvic Vasculature as an Adjuvant Therapy in Cases of Placenta Accreta</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Placenta accreta is a relatively rare event, in which the placenta is abnormally implanted
      into the uterine myometrium. The most significant complication is intense bleeding, mainly
      during labor. The most important risk factors are previous cesarean delivery, placenta
      previa, and advanced maternal age. Cesarean hysterectomy is the recommended management.
      During the recent years, inserting intravascular balloon catheter for occlusion and/or
      arterial embolization, was introduced as an adjuvant therapy in order to minimize blood loss
      during cesarean hysterectomy or in conduct with conservative management with the intent of
      avoiding hysterectomy in selective cases. Contradicting reports exist regarding the
      effectiveness and safety of the catheters in cases of placenta accreta. The objective of this
      study is to estimate the efficacy of the balloon catheters among women diagnosed with a
      placenta accreta.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of blood products transfused</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need for hysterectomy</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>catheter`s side effects</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalization</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Post Partum Bleeding</condition>
  <arm_group>
    <arm_group_label>internal iliac catheterization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women in this arm will undergo internal iliac artery catheterization prior to the cesarean delivery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no intervention prior to cesarean</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>internal iliac catheterization</intervention_name>
    <description>Women in this arm will undergo internal iliac artery catheterization prior to the cesarean delivery</description>
    <arm_group_label>internal iliac catheterization</arm_group_label>
    <other_name>internal iliac artery catheterization</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pregnant women age 18-45

          -  antepartum diagnosis of placenta accreta

        Exclusion Criteria:

        - women who refuse to participate
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raed Salim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dep. OB/GYN, HaEmek Medical Center, Afula, Israel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Haemek Medical Center</name>
      <address>
        <city>Afula</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2011</study_first_submitted>
  <study_first_submitted_qc>June 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2011</study_first_posted>
  <last_update_submitted>June 14, 2015</last_update_submitted>
  <last_update_submitted_qc>June 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>HaEmek Medical Center, Israel</investigator_affiliation>
    <investigator_full_name>Raed Salim</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Placenta accreta</keyword>
  <keyword>Internal iliac artery catheterization</keyword>
  <keyword>Post partum bleeding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Placenta Accreta</mesh_term>
    <mesh_term>Postpartum Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

